Alzinova gets FDA Fast Track nod for Alzheimer’s vaccine

Vaccine selectively targets toxic forms of amyloid-beta that impair synaptic function and contribute to cognitive decline. Swedish biotech Alzinova has received Fast Track designation from the US FDA for its vaccine targeting Alzheimer’s disease. The news comes hot on the heels of the company securing FDA approval of its Investigational New Drug (IND) application, allowing […] The post Alzinova gets FDA Fast Track nod for Alzheimer’s vaccine appeared first on Longevity.Technology.